www.alldocs.info « heartdiseases »
by www.alldocs.info
the most recent document references on :: heart diseases
Google
 
 Web   heartdiseases.alldocs.info 
 
    Languages: malattie cardiovascolari  heart diseases  enfermedades cardiovasculares  maladies cardiovasculaires  Herzkrankheiten          Found 2286 documents         Page 14 of 77   Pages:  <<  <  9  10  11  12  13  14  15  16  17  18  19  >  >> 
 
 
 
   heart diseases heart diseases
     hypertension hypertension
  heartdiseases.alldocs.infohomepage
www.alldocs.infowww.alldocs.info


 

  Legenda: last week last month

  [391] uncomplicated hypertension Thiazides could achieve major cost ...
      PDF [85,0 KB]  From [bmj.bmjjournals.com]  Last viewed: 21.09.2006
The American Society of Hypertension , Inc. 148 Madison Avenue, Fifth Floor, NY, New York 10016-6700 • (212) 696-9099 • Fax (212) 696-0711 www.ash-us.org Embargoed For Release: Thursday, May 18, 2006 - 12:01am EDT Contacts: Mel Granick Susan Rood 212-884-0660/0650 212-884-0643/0650 mgranick@chamberlainpr.com srood@chamberlainpr.com ASH Press Room May 16-20 212-261-6184 Study of American Indians Indicates Racial and Gender Disparities in Development of Hypertension Findings from The Strong Heart Study Examined at 21 st Annual Scientific Meeting of American Society of Hypertension NEW YORK, May 18, 2006 – Data from the largest epidemiological study of cardiovascular disease (CVD) and its risk factors in the American Indian community may indicate racial differences in the development of hypertension and that ...

  [392] Reflections on Hypertension Control Rates
      PDF   From [archinte.ama-assn.org]  Last viewed: 21.09.2006
The American Society of Hypertension , Inc. 148 Madison Avenue, Fifth Floor, NY, New York 10016-6700 • (212) 696-9099 • Fax (212) 696-0711 www.ash-us.org Embargoed For Release: Thursday, May 18, 2006 - 12:01am EDT Contacts: Mel Granick Susan Rood 212-884-0660/0650 212-884-0643/0650 mgranick@chamberlainpr.com srood@chamberlainpr.com ASH Press Room May 16-20 212-261-6184 Study of American Indians Indicates Racial and Gender Disparities in Development of Hypertension Findings from The Strong Heart Study Examined at 21 st Annual Scientific Meeting of American Society of Hypertension NEW YORK, May 18, 2006 – Data from the largest epidemiological study of cardiovascular disease (CVD) and its risk factors in the American Indian community may indicate racial differences in the development of hypertension and that ...

  [393] Epoprostenol (Prostacyclin) and Pulmonary Hypertension
      PDF [49,2 KB]  From [www.annals.org]  Last viewed: 21.09.2006
The American Society of Hypertension , Inc. 148 Madison Avenue, Fifth Floor, NY, New York 10016-6700 • (212) 696-9099 • Fax (212) 696-0711 www.ash-us.org Embargoed For Release: Thursday, May 18, 2006 - 12:01am EDT Contacts: Mel Granick Susan Rood 212-884-0660/0650 212-884-0643/0650 mgranick@chamberlainpr.com srood@chamberlainpr.com ASH Press Room May 16-20 212-261-6184 Study of American Indians Indicates Racial and Gender Disparities in Development of Hypertension Findings from The Strong Heart Study Examined at 21 st Annual Scientific Meeting of American Society of Hypertension NEW YORK, May 18, 2006 – Data from the largest epidemiological study of cardiovascular disease (CVD) and its risk factors in the American Indian community may indicate racial differences in the development of hypertension and that ...

  [394] Editorial Does an impaired flow mediated vasodilatation predict ...
      PDF [137,4 KB]  From [heart.bmjjournals.com]  Last viewed: 21.09.2006
The Dietary Approaches to Stop Hypertension study (DASH) Page 1 of 11 Dietary Approaches to Stop Hypertension (DASH) Data Distribution Agreement The National Heart, Lung, and Blood Institute (NHLBI) and (Name of Recipient Organization) hereby enter into this Distribution Agreement as of the date specified on the final page hereof. PRELIMINARY STATEMENT The National Heart, Lung, and Blood Institute (NHLBI) has supported collection of data from participants in the Dietary Approaches to Stop Hypertension (DASH), hereafter referred to as “Study”. This well-characterized population provides a rare and valuable scientific resource. Promoting optimal use on a national scale of such a resource will require a large and concerted effort which may exceed the research capacity of currently available Study investigators. The NHLBI and the researchers it supports have a responsibility to the public in general, ...

  [395] Drug treatment of hypertension: implications of ALLHAT
      PDF [128,0 KB]  From [heart.bmjjournals.com]  Last viewed: 21.09.2006
The Dietary Approaches to Stop Hypertension study (DASH) Page 1 of 11 Dietary Approaches to Stop Hypertension (DASH) Data Distribution Agreement The National Heart, Lung, and Blood Institute (NHLBI) and (Name of Recipient Organization) hereby enter into this Distribution Agreement as of the date specified on the final page hereof. PRELIMINARY STATEMENT The National Heart, Lung, and Blood Institute (NHLBI) has supported collection of data from participants in the Dietary Approaches to Stop Hypertension (DASH), hereafter referred to as “Study”. This well-characterized population provides a rare and valuable scientific resource. Promoting optimal use on a national scale of such a resource will require a large and concerted effort which may exceed the research capacity of currently available Study investigators. The NHLBI and the researchers it supports have a responsibility to the public in general, ...

  [396] Hypertension Associated With Diabetes Mellitus-Past and Future
      PDF [229,2 KB]  From [jasn.asnjournals.org]  Last viewed: 21.09.2006
The Dietary Approaches to Stop Hypertension study (DASH) Page 1 of 11 Dietary Approaches to Stop Hypertension (DASH) Data Distribution Agreement The National Heart, Lung, and Blood Institute (NHLBI) and (Name of Recipient Organization) hereby enter into this Distribution Agreement as of the date specified on the final page hereof. PRELIMINARY STATEMENT The National Heart, Lung, and Blood Institute (NHLBI) has supported collection of data from participants in the Dietary Approaches to Stop Hypertension (DASH), hereafter referred to as “Study”. This well-characterized population provides a rare and valuable scientific resource. Promoting optimal use on a national scale of such a resource will require a large and concerted effort which may exceed the research capacity of currently available Study investigators. The NHLBI and the researchers it supports have a responsibility to the public in general, ...

  [397] Cardiovascular Prognosis of “Masked Hypertension” Detected by ...
      PDF   From [jama.ama-assn.org]  Last viewed: 21.09.2006
Easing the pressure:tackling hypertension • B:Reducing the burden:tackling hypertension 25 This section of the toolkit looks at ways of reducing the burden of hypertension through prevention and control.It considers the broad principles involved and some of the evidence supporting particular approaches. There are two basic elements to any strategy to tackle hypertension and reduce its burden: • preventing it developing in the first place by reducing the modifiable risk factors,and • detecting,treating and controlling hypertension in those who already have the condition. Preventing hypertension There are two broad approaches to preventing hypertension : • the whole population approach,and • the ‘at-risk’individual or group approach. These two approaches are not mutually exclusive,and it has been argued that both are necessary in any comprehensive strategy. ...

  [398] Pediatric Hypertension: A Review for the Primary Care Provider
      PDF   From [cpj.sagepub.com]  Last viewed: 21.09.2006
HYPERTENSION Clinical Practice Guidelines Page 2 HIP guidelines are not a substitute for the clinical judgment of the healthcare practitioner and are intended only to assist the practitioner by organizing relevant information on the management of preventive care and certain disease states. Individual patient treatment may vary from this guideline based on the healthcare practitioner’s clinical judgment. Evaluation Classification of Blood Pressure (BP)* Category SBP mmHg DBP mmHg Normal < 120 and < 80 Prehypertension 120-139 or 80-89 Hypertension , Stage 1 140-159 or 90-99 Hypertension , Stage 2 = 160 or = 100 * See Blood Pressure Measurement Techniques. Key: SBP = Systolic Blood Pressure; DBP = Diastolic Blood Pressure Diagnostic Workup of Hypertension ...

  [399] Hypertension, Diabetes Mellitus, Hypercholesterolemia, and ...
      PDF [21,7 KB]  From [circ.ahajournals.org]  Last viewed: 21.09.2006
1 2/2005 Details of recommendations can be found in the main text at the pages indicated. C Grade hypertension according to systolic and diastolic BP levels. (pg 13) Grade C, Level IV C Use the following procedures when recording BP: • allow the patient to sit or lie down for several minutes before measuring the BP • the 30 minutes preceding the measurement • bladder for fat arms. least 80% of the arm. • diastolic BP • measure the BP in both arms at the first visit • take 2 or more readings separated by 2 minutes. should be obtained and averaged. MOH CLINICAL PRACTICE GUIDELINES Hypertension Executive summary of recommendations Definition of high blood pressure Evaluation of high blood pressure the patient ...

  [400] References Plexiform Lesion in Severe Pulmonary Hypertension ...
      PDF [145,3 KB]  From [ajp.amjpathol.org]  Last viewed: 21.09.2006
Last update: July 30, 2006 – 6:12 PM Hypertension implant has promise A Maple Grove firm's device to lower stubbornly high blood pressure is attracting attention -- and deep-pocket investors, as well. Susan E. Peterson, Star Tribune Rheos implant In the lobby of med-tech firm CVRx Inc. hangs a framed snapshot that makes CEO Robert Kieval smile: a masked surgeon in an operating room holds up a piece of notebook paper on which he's scrawled, "It works." The photo was taken during the first operation on a human patient to implant the company's Rheos system, a device designed to help control high blood pressure in patients whose condition can't be controlled with medication. The device, similar in size to a pacemaker, still is undergoing clinical trials and has a long way to go to win regulatory approval as being safe and effective. Kieval said it will be several years before it could ...

  [401] Soluble thrombomodulin concentration is raised in scleroderma ...
      PDF [158,0 KB]  From [ard.bmjjournals.com]  Last viewed: 21.09.2006
Last update: July 30, 2006 – 6:12 PM Hypertension implant has promise A Maple Grove firm's device to lower stubbornly high blood pressure is attracting attention -- and deep-pocket investors, as well. Susan E. Peterson, Star Tribune Rheos implant In the lobby of med-tech firm CVRx Inc. hangs a framed snapshot that makes CEO Robert Kieval smile: a masked surgeon in an operating room holds up a piece of notebook paper on which he's scrawled, "It works." The photo was taken during the first operation on a human patient to implant the company's Rheos system, a device designed to help control high blood pressure in patients whose condition can't be controlled with medication. The device, similar in size to a pacemaker, still is undergoing clinical trials and has a long way to go to win regulatory approval as being safe and effective. Kieval said it will be several years before it could ...

  [402] A National Pulmonary Hypertension Service for England & Wales: an ...
      PDF [138,5 KB]  From [thorax.bmjjournals.com]  Last viewed: 21.09.2006
New Research Initiatives at Wright State Use Genetic Models to Understand Hypertension by Mark Willis Using genetic research techniques to study hyper- tension is not a simple process, according to Mariana Morris, Ph.D. Hypertension does not fit into a mono- genetic model; many genes on different chromosomes influence how the body regu- lates blood pressure. “It’s probably the interaction of those genes with the environment that results in hypertension ,” Dr. Morris says. Mariana Morris, Ph.D., was appointed chair of the Department of Pharmacology and Toxicology at Wright State University School of Medicine in 1997. She came to Wright State from Wake Forest Univer- sity School of Medicine in North Carolina, where she was professor of physiology and pharmacology and an associate in the Hypertension Center in the Depart- ment of Surgical Sciences. Hypertension and how ...

  [403] Effect of Liver Damage on Experimental Renal Hypertension in the Rat
      PDF [1513,9 KB]  From [circres.ahajournals.org]  Last viewed: 21.09.2006
  hypertension  1581           Kidney Disease and Its Leading Causes: Diabetes and Hypertension   A Brown-Bag Presentation by Robert Beallo, M.D. Sponsored by LBNL Health Care Facilitator Program March 31, 2005 Perseverance Hall           The Real Epidemics in Our Community: Hypertension , Diabetes, and Obesity   Epidemic: a disease or condition which is highly prevalent in a community or large geographical area. High blood pressure : affects approximately 25% of people in the United States. Obesity : affects approximately 30% of people in the United States. Diabetes : affects approximately 8% of people in the United States.           High Blood Pressure/ Hypertension   What is hypertension (HTN): a blood pressure reading more than 140/90 about 25% of U.S. ...

  [404] Section 6: Hypertension
      PDF   From [www.paho.org]  Last viewed: 21.09.2006
Section 6: Hypertension Summary of Recommendations Clinical Prevention. Guide for physicians.---Washington, DC: PAHO, 1998. 334 pp. - Scientific Publication; 568 Measurement of blood pressure. [All persons 21–64 years of age should be checked.] Reasonable evidence for inclusion in the periodic health examination (PHE). Recommendation type: (B) Pharmacological treatment of hypertension . [Persons aged 21– 64 with diastolic pressure of 90 mm Hg or higher: treatment reduces the risk of stroke, heart disease, or death.] Strong evidence of response to treatment. Recommendation type: (A) Proposed Basic Indicators No. Indicator Numerator/denominator X 100 Total no. of persons with BP = 140/90 or who are being treated with drugs 1. Prevalence of hypertension Total no. of persons in the study No. of persons who know they have hypertension 2. Persons who know ...

  [405] CARDIOVASCULAR WAIVERS CONDITION: HYPERTENSION (ICD9 401.9 ...
      PDF   From [www.rucker.amedd.army.mil]  Last viewed: 21.09.2006
CARDIOVASCULAR WAIVERS CONDITION: HYPERTENSION (ICD9 401.9) Revised 01 November 2001 AEROMEDICAL CONCERNS : Untreated hypertension is a major risk factor for the development of cardiovascular disease including coronary artery disease, congestive heart failure, cerebrovascular accidents, peripheral vascular disease, and renal disease. The relative risk of developing coronary artery disease is compounded when untreated hypertension co-exists with hyperlipidemia, cigarette smoking, increasing age, or diabetes. WAIVERS : Waivers for hypertension are routinely granted for Class 2, 3, & 4 aircrew members when treatment has achieved a normotensive state (less than 140/90 mm Hg) and evaluation reveals no underlying pathology. Individuals controlled with lifestyle modifications alone will also require a waiver even though control is achieved without medication. INFORMATION REQUIRED : The goal of initial work-up ...

  [406] Statistical Brief #59: Hypertension in America, 2002: Estimates ...
      PDF   From [www.meps.ahrq.gov]  Last viewed: 21.09.2006
Agency for Healthcare Medical Expenditure Panel Survey Research and Quality STATISTICAL BRIEF #59 December 2004 Hypertension in America, 2002: Estimates for the U.S. Civilian Non- institutionalized Population Ages 18 and Older William Carroll, BS Introduction Hypertension , commonly referred to as high blood pressure, is a serious medical condition which, if not controlled, can lead to more serious cardiovascular conditions. Data from the Household Component of the 2002 Medical Expenditure Panel Survey (MEPS­ HC) show that an estimated 21.3 percent or 45.3 million adults 18 years old and older had been told by a health care professional at two or more different medical visits that they had hypertension . This estimate is based on reports for all household members by a single household respondent during the ...

  [407] Primary Health Care Practice Audits: Diabetes and Hypertension ...
      PDF   From [gov.ns.ca]  Last viewed: 21.09.2006
Strengthening Primary Care: Summary of Evaluation Results Primary Health Care Practice Audits: Diabetes and Hypertension Summary Report September, 2004 Graham L, Consultant to the Primary Health Care Section, Nova Scotia Department of Health Background This chart audit is a component of a primary care initiative created to implement and evaluate new models of primary care in Nova Scotia. The three main components to the Initiative implemented at each of the four demonstration sites were: to introduce inter-disciplinary teams involving at least one nurse practitioner and one family physician, to adopt and use computerized information systems to support primary health care service delivery and to adopt alternative payment mechanisms for primary care physicians. The primary purpose of the chart audit was to determine the impact of project ...

  [408] Hypertension or high blood pressure
      PDF   From [www.betterhealth.vic.gov.au]  Last viewed: 21.09.2006
Hypertension or high blood pressure The heart pumps blood around the body through the blood vessels. Blood pressure is the amount of force exerted on the artery walls by the pumping blood. High blood pressure ( hypertension ) means that your blood is pumping with more force than normal through your arteries. The added stress on the arteries can accelerate the silting of arteries with fatty plaques (atherosclerosis). Other risk factors for atherosclerosis include cigarette smoking and high blood cholesterol. Atherosclerosis contributes to many illnesses, such as heart attack and stroke. Hypertension is a common disorder of the circulatory system, affecting around one in seven adult Australians. Hypertension usually produces no symptoms. This means most people don’t even realise they have it. Experts recommend that everyone should have their blood pressure checked regularly. ...

  [409] Persistent Pulmonary Hypertension of the Newborn
      PDF   From [www.mgh.harvard.edu]  Last viewed: 21.09.2006
Persistent Pulmonary Hypertension of the Newborn; Roberts et al. 1995 1 Persistent Pulmonary Hypertension of the Newborn Jesse D. Roberts, Jr., M.D., M.S. A. Pathophysiology • Increased PVR • Restrictive lung vascular disease • Pulmonary artery smooth muscle hypertrophy and hyperplasia • Observed in newborns that have died from PPHN • Observed in animal models of PPHN • Decreased pulmonary vascular cross sectional area • Constrictive vascular disease • Active contraction and abnormal reactivity of pulmonary artery smooth muscle • Increased PVR and in utero hypoxemia causes • Tricuspid regurgitation • Dilated right ventricle • Right to left shunt of deoxygenated blood • via PDA • ...

  [410] 2006 HYPERTENSION GUIDELINE WORKSHOP
      DOC   From [www.hypertension.org.za]  Last viewed: 21.09.2006
  hypertension    THE SOUTHERN AFRICAN HYPERTENSION SOCIETY invites you to the 2006 HYPERTENSION GUIDELINE WORKSHOP (CPD accredited - 5 points) Come and hear the experts!   DATE:   Saturday, 30 th September 2006 TIME:   Registration from 09:00        09h30 to 15h30 VENUE:   VW Conference Centre, Midrand PRESENTERS: Prof. John Milne and Prof. Joe Veriava PROGRAMME: BP measurement Assessing cardiovascular risk Routine investigations BP targets Deciding treatment on options using the new algorithm Compelling indications for certain medications Resistant (stage 3) hypertension Case studies will be used throughout to illustrate the guideline   This workshop is sponsored by unrestricted educational grants from: ...

  [411] hypertension toolkit aw pdf_2
      PDF   From [www.fph.org.uk]  Last viewed: 21.09.2006
Easing the pressure:tackling hypertension • B:Reducing the burden:tackling hypertension 25 This section of the toolkit looks at ways of reducing the burden of hypertension through prevention and control.It considers the broad principles involved and some of the evidence supporting particular approaches. There are two basic elements to any strategy to tackle hypertension and reduce its burden: • preventing it developing in the first place by reducing the modifiable risk factors,and • detecting,treating and controlling hypertension in those who already have the condition. Preventing hypertension There are two broad approaches to preventing hypertension : • the whole population approach,and • the ‘at-risk’individual or group approach. These two approaches are not mutually exclusive,and it has been argued that both are necessary in any comprehensive strategy. ...

  [412] Statistical Brief #119: Diuretic Use in the Treatment of ...
      PDF   From [www.meps.ahrq.gov]  Last viewed: 21.09.2006
Medical Expenditure Panel Survey Agency for Healthcare Research and Quality STATISTICAL BRIEF #119 March 2006 Diuretic Use in the Treatment of Hypertension , by Selected Population Characteristics, 2003 Highlights In 2003, females age 18 and older who were reported as receiving treatment for hypertension were more likely (49.5 percent) to use a diuretic than males (40.2 percent). More than half (52.6 percent) of elderly adults who were reported as receiving treatment for hypertension used a diuretic in 2003. This was larger than the proportion of adults ages 45 to 64 (43.7 percent) and young adults ages 18 to 44 (26.7 percent). Among adults reported as receiving treatment for hypertension in 2003, black non-Hispanics (53.2 percent) were more likely ...

  [413] Title : Perioperative Nitroglycerin in a Patient with Pulmonary ...
      PDF [13,2 KB]  From [www.usc.edu]  Last viewed: 10.07.2006

  [414] Title : Perioperative Management of Severe Pulmonary Hypertension ...
      PDF [14,5 KB]  From [www.usc.edu]  Last viewed: 10.07.2006

  [415] Hypertension
      PDF [406,0 KB]  From [ww2.heartandstroke.ca]  Last viewed: 10.07.2006

  [416] Diet and Hypertension
      PPT [151,0 KB]  From [extension.missouri.edu]  Last viewed: 10.07.2006

  [417] hypertension toolkit aw pdf_2
      PDF [50,1 KB]  From [www.fphm.org.uk]  Last viewed: 10.07.2006

  [418] hypertension toolkit aw pdf_2
      PDF [58,8 KB]  From [www.fphm.org.uk]  Last viewed: 10.07.2006

  [419] Hypertension Control in the World: An Agenda for the Coming Decade
      PDF [13,1 KB]  From [hsc.utoledo.edu]  Last viewed: 10.07.2006

  [420] The World Hypertension League Objectives
      PDF [31,9 KB]  From [hsc.utoledo.edu]  Last viewed: 10.07.2006